shr-1139
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 26, 2024 (NCT07051538)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07232576 | Phase 2 | Nov 30, 2025 | Hengrui Therapeutics, Inc. |
| NCT07078695 | Phase 1 | Aug 19, 2025 | Atridia Pty Ltd. |
| NCT06875934 | Phase 2 | Mar 28, 2025 | Hengrui Therapeutics, Inc. |
| NCT07051538 | Phase 1 | Jun 26, 2024 | Hengrui Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2024 |
| Atridia Pty Ltd. | For profit | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1